Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01813214
Title The Effects of Vemurafenib on Immunity in Patients With Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Lombardi Comprehsnive Cancer Center Washington District of Columbia 20007 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Virginia Health System Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field